Differential immediate and sustained memory enhancing effects of alpha7 nicotinic receptor agonists and allosteric modulators in rats

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Thomsen, Morten S ^a   El Sayed, Mona ^a   Mikkelsen, Jens D ^a,b  

^a Mental Health Services CPH   (Denmark)

^b NEUROSEARCH A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

A 582941; AVL 3288; BINDING PROTEIN; BUNGAROTOXIN RECEPTOR; BUNGAROTOXIN RECEPTOR MODULATOR; BUNGAROTOXIN RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR AFFECTING AGENT; MESSENGER RNA; PNU 120596; PROTEIN LY6H; PROTEIN LYNX1; PROTEIN LYNX2; PROTEIN PSCA; PROTEIN RIC3; UNCLASSIFIED DRUG; XY 4083; 1 (5 CHLORO 2,4 DIMETHOXYPHENYL) 3 (5 METHYLISOXAZOL 3 YL)UREA; 1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-METHYLISOXAZOL-3-YL)UREA; A-582941; CARBANILAMIDE DERIVATIVE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ISOXAZOLE DERIVATIVE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; PYRIDAZINE DERIVATIVE; PYRROLE DERIVATIVE; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; COGNITION; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFECT; FRONTAL CORTEX; HIPPOCAMPUS; NONHUMAN; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; REPEATED DRUG DOSE; SHORT TERM MEMORY; SINGLE DRUG DOSE; SOCIAL DISCRIMINATION; ANIMAL; GENETICS; IN SITU HYBRIDIZATION; MALE; MEMORY; METABOLISM; WISTAR RAT;

LYNX; RATTUS;

ANIMALS; GPI-LINKED PROTEINS; IN SITU HYBRIDIZATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOXAZOLES; MALE; MEMORY; MEMORY, SHORT-TERM; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PHENYLUREA COMPOUNDS; PYRIDAZINES; PYRROLES; RATS; RATS, WISTAR; RECEPTORS, NICOTINIC; RNA, MESSENGER;

EID: 80655141560     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027014     Document Type: Article

References (40)

1. Haydar SN, Dunlop J, (2010) Neuronal nicotinic acetylcholine receptors- targets for the development of drugs to treat cognitive impairment associated with schizophrenia and Alzheimer's disease. Curr Top Med Chem 10: 144-52.
2. Faghih R, Gopalakrishnan M, Briggs CA, (2008) Allosteric modulators of the alpha7 nicotinic acetylcholine receptor. J Med Chem 51: 701-12.
3. Bertrand D, Devillers-Thiéry A, Revah F, Galzi JL, Hussy N, et al. (1992) Unconventional pharmacology of a neuronal nicotinic receptor mutated in the channel domain. Proc Natl Acad Sci U S A 89: 1261-5.
4. Dani JA, Radcliffe KA, Pidoplichko VI, (2000) Variations in desensitization of nicotinic acetylcholine receptors from hippocampus and midbrain dopamine areas. Eur J Pharmacol 393: 31-8.
5. Deutsch SI, Schwartz BL, Schooler NR, Rosse RB, Mastropaolo J, et al. (2008) First administration of cytidine diphosphocholine and galantamine in schizophrenia: a sustained alpha7 nicotinic agonist strategy. Clin Neuropharmacol 31: 34-9.
6. Papke RL, Kem WR, Soti F, López-Hernández GY, Horenstein NA, (2009) Activation and desensitization of nicotinic alpha7-type acetylcholine receptors by benzylidene anabaseines and nicotine. J Pharmacol Exp Ther 329: 791-807.
7. Thomsen MS, Hansen HH, Timmermann DB, Mikkelsen JD, (2010) Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology. Curr Pharm Des 16: 323-43.
8. Bjugstad KB, Mahnir VM, Kem WR, Socci DJ, Arendash GW, (1996) Long-term treatment with GTS-21 or nicotine enhances water maze performance in aged rats without affecting the density of nicotinic receptor subtypes in neocortex. Drug Development Research 39: 19-28.
9. Stevens KE, Kem WR, Mahnir VM, Freedman R, (1998) Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacology (Berl) 136: 320-7.
10. Levin ED, Bettegowda C, Blosser J, Gordon J, (1999) AR-R17779, an alpha7 nicotinic agonist, improves learning and memory in rats. Behav Pharmacol 10: 675-80.
11. Bitner RS, Bunnelle WH, Anderson DJ, Briggs CA, Buccafusco J, et al. (2007) Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways. J Neurosci 27: 10578-87.
12. Pichat P, Bergis OE, Terranova J-P, Urani A, Duarte C, et al. (2007) SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia. Neuropsychopharmacology 32: 17-34.
13. Li J-G, Lehr M, Liu-Chen L-Y, Woodruff-Pak DS, (2008) Nicotinic acetylcholine receptors and modulation of learning in 4- and 27-month-old rabbits. Neuropsychopharmacology 33: 2820-30.
14. Hauser TA, Kucinski A, Jordan KG, Gatto GJ, Wersinger SR, et al. (2009) TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia. Biochem Pharmacol 78: 803-12.
15. Buccafusco JJ, Letchworth SR, Bencherif M, Lippiello PM, (2005) Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance. Trends Pharmacol Sci 26: 352-60.
16. Briggs CA, Anderson DJ, Brioni JD, Buccafusco JJ, Buckley MJ, et al. (1997) Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo. Pharmacol Biochem Behav 57: 231-41.
17. Abdulla FA, Bradbury E, Calaminici MR, Lippiello PM, Wonnacott S, et al. (1996) Relationship between up-regulation of nicotine binding sites in rat brain and delayed cognitive enhancement observed after chronic or acute nicotinic receptor stimulation. Psychopharmacology (Berl) 124: 323-31.
18. Werkheiser JL, Sydserff S, Hubbs SJ, Ding M, Eisman MS, et al. (2011) Ultra-low exposure to alpha-7 nicotinic acetylcholine receptor partial agonists elicits an improvement in cognition that corresponds with an increase in alpha-7 receptor expression in rodents: implications for low dose clinical efficacy. Neuroscience 186: 76-87.
19. Castner SA, Smagin GN, Piser TM, Wang Y, Smith JS, et al. (2011) Immediate and sustained improvements in working memory after selective stimulation of α7 nicotinic acetylcholine receptors. Biol Psychiatry 69: 12-8.
20. Grønlien JH, Håkerud M, Ween H, Thorin-Hagene K, Briggs CA, et al. (2007) Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes. Mol Pharmacol 72: 715-24.
21. Hurst RS, Hajós M, Raggenbass M, Wall TM, Higdon NR, et al. (2005) A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization. J Neurosci 25: 4396-405.
22. Ng HJ, Whittemore ER, Tran MB, Hogenkamp DJ, Broide RS, et al. (2007) Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators. Proc Natl Acad Sci U S A 104: 8059-64.
23. Timmermann DB, Grønlien JH, Kohlhaas KL, Nielsen EØ, Dam E, et al. (2007) An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo. J Pharmacol Exp Ther 323: 294-307.
24. Dunlop J, Lock T, Jow B, Sitzia F, Grauer S, et al. (2009) Old and new pharmacology: positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor by the 5-hydroxytryptamine(2B/C) receptor antagonist SB-206553 (3,5-dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b′]di pyrrole-1(2H)-carboxamide). J Pharmacol Exp Ther 328: 766-76.
25. Dinklo T, Shaban H, Thuring JW, Lavreysen H, Stevens KE, et al. (2011) Characterization of 2-[[4-fluoro-3-(trifluoromethyl)phenyl]amino]-4-(4-pyridinyl)-5-thiazolemethanol (JNJ-1930942), a novel positive allosteric modulator of the {alpha}7 nicotinic acetylcholine receptor. J Pharmacol Exp Ther 336: 560-74.
26. Christensen DZ, Mikkelsen JD, Hansen HH, Thomsen MS, (2010) Repeated administration of alpha7 nicotinic acetylcholine receptor (nAChR) agonists, but not positive allosteric modulators, increases alpha7 nAChR levels in the brain. J Neurochem 114: 1205-16.
27. Hashimoto K, Ishima T, Fujita Y, Matsuo M, Kobashi T, et al. (2008) Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711. Biol Psychiatry 63: 92-7.
28. Keller JJ, Keller AB, Bowers BJ, Wehner JM, (2005) Performance of alpha7 nicotinic receptor null mutants is impaired in appetitive learning measured in a signaled nose poke task. Behav Brain Res 162: 143-52.
29. Young JW, Crawford N, Kelly JS, Kerr LE, Marston HM, et al. (2007) Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. Eur Neuropsychopharmacol 17: 145-55.
30. Reymond J-L, van Deursen R, Bertrand D, (2011) What we have learned from crystal structures of proteins to receptor function. Biochem Pharmacol In press.
31. Pepeu G, Giovannini MG, (2004) Changes in acetylcholine extracellular levels during cognitive processes. Learn Mem 11: 21-7.
32. Millar NS, (2008) RIC-3: a nicotinic acetylcholine receptor chaperone. Br J Pharmacol 153 (Suppl): S177-83.
33. Treinin M, (2008) RIC-3 and nicotinic acetylcholine receptors: biogenesis, properties, and diversity. Biotechnol J 3: 1539-47.
34. Miwa JM, Freedman R, Lester HA, (2011) Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses. Neuron 70: 20-33.
35. Thomsen MS, Mikkelsen JD, (2011) The α7 nicotinic acetylcholine receptor complex: one, two or multiple drug targets? Curr Drug Targets in press.
36. Tekinay AB, Nong Y, Miwa JM, Lieberam I, Ibanez-Tallon I, et al. (2009) A role for LYNX2 in anxiety-related behavior. Proc Natl Acad Sci U S A 106: 4477-82.
37. Engelmann M, Wotjak CT, Landgraf R, (1995) Social discrimination procedure: an alternative method to investigate juvenile recognition abilities in rats. Physiol Behav 58: 315-21.
38. Schmittgen TD, Livak KJ, (2008) Analyzing real-time PCR data by the comparative CT method. Nature Protocols 3: 1101-1108.
39. Pei Q, (2003) Antidepressant drug treatment induces Arc gene expression in the rat brain. Neuroscience 121: 975-982.
40. Woldbye DP, Greisen MH, Bolwig TG, Larsen PJ, Mikkelsen JD, (1996) Prolonged induction of c-fos in neuropeptide Y- and somatostatin-immunoreactive neurons of the rat dentate gyrus after electroconvulsive stimulation. Brain Res 720: 111-9.